Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized double-blind phase II dose-response study of topiroxostat tablets in gout with hyperuricemia
CTR20242693Phase 2Completed
- Sponsor
- Hunan Xianshi Pharmaceutical
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of topiroxostat in gout, hyperuricemia, sponsored by Hunan Xianshi Pharmaceutical. Started Jul 2024; status: completed.
02
Drugs
topiroxostat
03
Conditions
gouthyperuricemia
Beyond the preview
Go deeper on CTR20242693.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20242693.